Ads
related to: cancer cells, anti-cancer treatment- The Importance Of Testing
One Missed Patient Is One Too Many.
Visit Site For mNSCLC Testing Info.
- 1L Treatment Info
HCPs: It Is Up To You To Determine
If 1L Immunotherapy Is Appropriate.
- Metastatic NSCLC Testing
HCPs: Understand Your Patients'
Full Molecular Profiles. Learn More
- Confirm Mutational Status
Eligible mNSCLC Patient Should Be
Tested For Actionable Mutations.
- Don't Force Fit IO
1L IO May Not Be The Right Therapy
Option For Certain mNSCLC Patients.
- HCPs: It’s Up To You
Test mNSCLC Patients For Mutations
To Help Determine Treatment Options
- The Importance Of Testing
Search results
Anti-Cancer Drug Pembrolizumab: Frequently Used Alone Or With Other Treatments
Forbes· 4 days agoPembrolizumab, sold as Keytruda by Merck & Co., was one of the first inhibitors to hit the market. A...
Cell therapy reckoning: How a 'remarkable resolution of lupus' carried CAR-T from cancer to...
FierceBiotech· 11 hours agoThis story is part 3 in a four-part series about cell therapy created by the Fierce Biotech team....
Pulling out the stops: Deletion of regnase-1 promotes anti-tumor activity in NK cells
Medical Xpress· 9 hours agoNatural killer (NK) cells play a crucial role in the first line of host defense by eliminating...
Bone Cancer Breakthrough: UCL’s New T-Cell Therapy Shows Promise
SciTechDaily· 1 day agoA new immunotherapy developed at UCL using engineered immune cells has shown promising preclinical...
Gilead's Trodelvy fails to meet main goal in late-stage cancer study
AOL· 3 hours agoShares of Gilead fell 3.3% in extended trade after the company said the drug did not meet the main goal of overall survival. In the overall study population, there was a higher number of deaths ...
Cancer treatment may work best at the right time of day
Futurity· 1 day agoThe circadian clock can be leveraged to enhance the efficacy of checkpoint inhibitor cancer therapy,...
...Analysis, Highlighting Sunvozertinib as an Effective Treatment for Non-small Cell Lung Cancer...
FOX21 Colorado Springs· 7 days agoSHANGHAI, May 24, 2024 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing groundbreaking new medicines for the treatment of cancer ...
New immunotherapy could treat cancer in the bone
Medical Xpress· 1 day agoOsteosarcoma is the most common bone cancer in teenagers but is still relatively rare, with around 160 new cases each year in the UK. Meanwhile, more...
...IND Application for 225Ac-FL-020 for the Treatment of Metastatic Castration-Resistant Prostate ...
FOX 4 Kansas City· 24 hours agoFood and Drug Administration (FDA) for clinical trials of 225Ac-FL-020, its PSMA-targeted...
From Robust Response to Rapid Resistance
MedPage Today· 6 days agoDemonstrating efficacy across multiple tumor types, there is no question that ICIs have revolutionized our approach to treatment and are arguably the...